Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Phase III Randomized, Controlled Study of Theratope Vaccine for Metastatic Breast Cancer

NCT00003638 is registered in ClinicalTrials.gov with Oncothyreon Canada Inc. as lead sponsor.

NCT NCT00003638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Phase III Randomized, Controlled Study of Theratope Vaccine for Metastatic Breast Cancer
Lead sponsor
Oncothyreon Canada Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 31, 1999
Completion date
December 31, 2008
Enrollment
950 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer